Taipei, April 22 (CNA) An allegedly proposed acceptable daily intake (ADI) of the leanness-enhancing drug ractopamine, which was criticized by several consumer groups Sunday, is just a consensus reached in a food safety evaluation meeting, Food and Drug Administration (FDA) Director-General Kang Jaw-jou said that day.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Four things to know about Bongkrekic acid
03/28/2024 11:27 PM - Society
Tests on deceased in Taipei food poisoning case finds Bongkrekic acid
03/28/2024 11:05 PM - Society
5 people remain in critical condition due to food poisoning in Taipei
03/28/2024 10:13 PM - Culture
Harvard Film Archive to hold event honoring Taiwan director Edward Yang
03/28/2024 09:52 PM - Sports
Turnout for CPBL pre-season games nearly triples
03/28/2024 09:31 PM